(Q37074119)

18 August 2017

1 reference

title

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory (English)

1 reference

18 August 2017

1 reference

Zeina Nahleh

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

4

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

15-21

1 reference

Role of the androgen receptor in human breast cancer

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Roles of androgens in the development, growth, and carcinogenesis of the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Androgen receptors, serum androgen levels and survival of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Androgenic induction of growth and differentiation in the rodent uterus involves the modulation of estrogen-regulated genetic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Androgens induce divergent proliferative responses in human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

A new hormonal therapy for estrogen receptor-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3 beta,17 beta-diol in human mammary cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast cancer cells renders them responsive to hormonal manipulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Aromatization of Androgens by Human Abdominal and Breast Fat Tissue1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Overview of the pharmacology of the aromatase inactivator exemestane

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Recent advances in aromatase inhibitor therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

BRCA1 in hormonal carcinogenesis: basic and clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

The androgen receptor CAG repeat: a modifier of carcinogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.15

21 January 2018

Identifiers

DOI

10.2217/14796694.4.1.15

1 reference

18 August 2017

1 reference